510(k) Report

De Novo · Granted

Granted

ipsogen JAK2 RGQ PCR Kit

DEN160028De NovoGranted Mar 27, 2017269-day reviewClass II21 CFR 866.6070

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Qiagen, Inc. · PSU Jak2 Gene Mutation Detection Test

Granted on Mar 27, 2017 as a new device type through De Novo after a 269-day review. 1 later device descends from it.

Decided
Mar 27, 2017
Review
269 days
Class
Class II
Product code
PSU
Recalls
None

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2018: 1 descendant cleared201620182020202220242026
  1. This deviceDEN160028 ipsogen JAK2 RGQ PCR KitQiagen, Inc. · 2017
  2. Descendant · cites it directly · 0 of its ownK172287 ipsogen JAK2 RGQ PCR KitQiagen, Inc. · 2018

Most influential descendants

Showing 1 of 1 · See all
  • K172287ipsogen JAK2 RGQ PCR KitQiagen, Inc. · 2018 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)DEN160028ipsogen JAK2 RGQ PCR KitQiagen, Inc.2017—
+1K172287ipsogen JAK2 RGQ PCR KitQiagen, Inc.2018—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
FIG. 1 — Lineage of DEN160028, 2017–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

De Novo decisions do not claim a predicate device.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K172287ipsogen JAK2 RGQ PCR KitQiagen, Inc.20180

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K172287 (Qiagen, Inc., 2018) has gone furthest, with 0 descendants of its own.

How does its category compare?

All PSU devices

PSU Jak2 Gene Mutation Detection Test: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · PSU

1in 2018

2017: 12018: 1
2007high 1 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSU

Too few PSU 510(k)s in any year since 2007 to give a median.

Recalls per year · PSU

No recall names PSU since 2007.

Adverse event reports per year · PSU

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2025

MAUDE reports naming product code PSU, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20181—01
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The ipsogen JAK2 RGQ PCR Kit is a qualitative in vitro diagnostic test for the detection of the JAK2 V617F/G1849T allele in genomic DNA extracted from EDTA whole blood. The ipsogen JAK2 RGQ PCR Kit is a real time PCR test performed on the QIAGEN Rotor-Gene Q MDx instrument. The test is intended for use as an adjunct to evaluation of suspected Polycythemia Vera, in conjunction with other clinicopathological factors.

This test does not detect less common mutations associated with Polycythemia Vera including mutations in exon 12 and is not intended for stand-alone diagnosis of Polycythemia Vera.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “DEN160028: ipsogen JAK2 RGQ PCR Kit.” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN160028

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026